
Elders' shares fell over 20% after investors focused on weaker FY26 guidance, rising input and fuel costs, integration risks, despite strong half-year earnings growth driven by better conditions and Delta Agribusiness contributions, highlighting concerns about future margins and outlook uncertainty.

Pacific Edge (ASX: PEB) tests critical resistance near 0.240 after surging on draft Medicare coverage, a 75% increase in reimbursement rates, and a NZ$25.4 million capital raise. Strong volume supports the rally, but RSI near 70 warns of potential pullback risk.

Hawk Resources is an early-stage explorer targeting high-grade copper-gold in Utah and lithium in Brazil, with emerging exposure to rare earths. Recent trading was driven by its Olympus scandium deal, a A$5.87A$5.87 million raising, and renewed momentum at Cactus.

Lumos Diagnostics shares have dropped sharply after last year’s rally, with weak technical signals and dilution concerns weighing on sentiment. Despite long-term optimism around FebriDx and US commercialisation, investors remain cautious due to slow revenue growth and ongoing funding pressures.

Commonwealth Bank of Australia (ASX: CBA) is facing weakening medium-term momentum after a sharp sell-off triggered by a quarterly profit miss, valuation concerns, rising policy risks, and margin pressure. Technically, the stock remains in a long-term uptrend but is testing critical support near $160.

Megaport (ASX: MP1) shares surged over 35% after the company secured AI infrastructure contracts worth A$254 million through Latitude.sh, strengthening its position in the booming AI compute and cloud connectivity market.